Henry Schein, Inc. (HSIC) has expanded its partnership with vVARDIS, gaining exclusive U.S. distribution rights for the Curodont Repair Fluoride Plus product starting January 1, 2026. This move is expected to bolster HSIC's Dental business and maintain positive stock momentum, building on previous strategic collaborations. The drill-free Curodont product addresses early-stage cavities, tapping into a significant market opportunity and aligning with the company's commitment to advancing oral health.

亨利香恩

<p>亨利香恩公司（Henry Schein, Inc.，HSIC）已扩大与 vVARDIS 的合作关系，从 2026 年 1 月 1 日起获得 Curodont Repair Fluoride Plus 产品在美国的独家分销权。这一举措预计将增强 HSIC 的牙科业务，并保持积极的股票动能，基于之前的战略合作。无钻孔的 Curodont 产品针对早期龋齿，抓住了一个重要的市场机会，并与公司推动口腔健康的承诺相一致</p>

亨利香恩的股票因与 vVARDIS 扩展合作伙伴关系而受益